PubMed دسترسی آزاد

Comparative Cost and Utilization Analysis of CAR-T Therapy and Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma in Germany: Insights from Statutory Health Insurance Billing and Nationwide Inpatient Data.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

PURPOSE: Chimeric Antigen Receptor (CAR) T-cell therapy has transformed the treatment of diffuse large B-cell lymphoma (DLBCL) but carries higher drug acquisition costs than autologous stem cell transplantation (autoSCT), while administration and follow-up costs remain underrepresented in economic evaluations and reimbursement decision-making. This study compares administration-related and subsequent treatment costs of CAR-T and autoSCT for DLBCL from the German statutory health insurance (SHI) perspective. METHODS: A two-step analysis based on two German databases was performed. In step 1, SHI billing data (representing 5 million insured individuals, ≙ 8% of SHI) from 2020-2022 were analyzed longitudinally. Costs were divided into initial regime (IR) (all services except CAR-T drug acquisition) and a following regime (FR). In step 2, a cross-sectional analysis of all German inpatient cases from 2020-2023 (17 million cases/year) assessed inpatient costs. RESULTS: Step 1 included 12 CAR-T and 59 autoSCT patients. Median IR costs per patient were €61,703 (CAR-T) versus €55,802 (autoSCT), while FR costs were lower for CAR-T (€44,832 versus €69,453). Most frequently reported adverse events (any grade) for CAR-T versus autoSCT were: B-cell aplasia/neutropenia (77% versus 64%), thrombocytopenia (38% versus 64%). Step 2 included 1,229 CAR-T and 2,239 autoSCT inpatient cases (2020-2023). Average LOS was comparable (27.3 versus 27.8 days), and average inpatient costs were lower for CAR-T (€13,991 versus €29,432). CONCLUSION: Although associated with higher IR costs, CAR-T therapy in DLBCL demonstrated lower inpatient and FR costs compared to autoSCT. This analysis focused on administration and follow-up costs, excluding drug acquisition costs, characterizing the economic burden beyond drug pricing.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل

کلیدواژه‌ها

CAR-TCostHealth economicsHematologyReal world dataStem cell transplant
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Persistence of cardiovascular risk factor changes after the great recession: fixed effects analysis of prospective cohort data from the multi-ethnic study of atherosclerosis.

OBJECTIVE: Multiple prospective cohort studies, including the multi-ethnic study of atherosclerosis (MESA), have documented elevations in cardiovascular risk factors after the Great Recession (GR) of 2008, despite other studies that report mortality declines after the GR. It is possible that the deleterious effects of the GR on cardiovascular risk profiles are short-lived and reversed. We examine whether risk factor elevations seen in …

PubMed2026

Efficacy of Local Treatment in Patients With Rheumatic Diseases Affecting the Temporomandibular Joint-A Systematic Review.

BACKGROUND: Temporomandibular joint (TMJ) involvement in rheumatic inflammatory arthropathies (RIA) has been sparsely described, and evidence regarding local treatment options for affected TMJs remains limited. OBJECTIVES: To perform a systematic review (SR) regarding local treatments for TMJ involvement in RIA and evaluate their effects on pain management, disease improvement, quality of life, health economics, and adverse events. MET…

PubMed2026

Impact and cost-effectiveness of national implementation of rotavirus vaccination in Vietnam: A modeling study.

BACKGROUND: In Vietnam, rotavirus remains a leading cause of severe acute gastroenteritis resulting in hospitalization. Although rotavirus vaccines are available in the private sector-primarily accessible to urban children-the Expanded Programme on Immunization has only piloted the vaccine in select provinces. This study assessed the impact and cost-effectiveness of national rotavirus vaccination in Vietnam to inform policy decision on…

PubMed2026

Professional Status of Audiology in U.S. Healthcare: A Health Economics Perspective.

Professional status in healthcare is determined not only by educational preparation or statutory scope of practice, but also by how a profession functions within reimbursement systems, labor markets, and healthcare delivery. This article applies a health economics framework to evaluate the current professional status of audiology in the United States using observable economic indicators rather than aspirational goals or regulatory inte…